Clinical trial

BVA-200 vs BVA-100 Validation Study

NCT06227819

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2023-05-23

PhaseN/A

Study timeline

Study start (actual)2023-05-23Date precision: day

Registry last updated2024-01-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

High Blood Pressureunresolved

High Cholesterolunresolved

Anemiaunresolved

Diabetesunresolved

Thyroid Diseasesunresolved

Kidney Diseasesunresolved

Clotting Disorderunresolved

Traumaunresolved

Other Diseaseunresolved

Interventions

BVA-200DIAGNOSTIC_TEST

Sponsors & collaborators

Daxor Corporationlead sponsor

Stern Cardiovascular Foundation, Inc.collaborator

Oregon Health and Science Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06227819 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.